Researchers at the University of Bonn, Germany, together with international colleagues, have found and further developed novel antibody fragments, so-called "nanobodies", against the SARS-CoV-2 virus.
Thanks to this new tool developed by Swedish researchers, the number of corona patient hospitalizations can be predicted three weeks in advance.
Scientists at the University of Seville may have found the reason why COVID-19 patients do not notice a life-threatening oxygen deficiency - or notice it much too late.
Apart from a lot of misery, the corona crisis also yields plenty of new insights into the treatment of other diseases.
Twenty percent of the Dutch population does not want to take the corona vaccine out of a fear of needles. AINAR offers a solution in the form of a game app.
British researchers have identified in a study five genes associated with the most severe form of COVID-19.
A face mask that constantly sterilizes itself is the solution for those who really want to take to the streets safely. It also helps to reduce waste.
A team of researchers from Munich University of Applied Sciences has examined to what extent transparent face shields are suitable for protection against infection with the coronavirus.
Jelmer Visser explains the movements of the corona pandemic in Europe for Innovation Origins. This week: Is there really light at the end of the tunnel?
AstraZeneca and Moderna have presented the interim results of their Phase 3 research. After a long wait, there are now three vaccines in sight instead of one.
Austrian researchers have shown in a study that natural UV radiation in winter is too weak to destroy SARS-CoV-2 viruses in aerosols and on surfaces.
Researchers at the University of Augsburg in Germany are working on an app that can detect an infection with the SARS CoV-2 coronavirus via speech. The app currently has an accuracy rate of over 80%.
The vaccine from Pfizer and BioNTech is 90 percent effective. Today, the companies announced the preliminary results of their phase three trials.
In this weekly section we give a follow-up to one of our best read stories. This week it was a story about loss of smell and taste in cases of COVID-19. But what else can the nose tell us?
British researchers have observed robust T-cell responses to SARS CoV-2 virus peptides in the majority of adults even six months after an asymptomatic or mild COVID-19 infection.
Days before corona officially appeared in Lombardy in February earlier this year, the virus had already settled in this northern Italian region. This is shown by data from the 112 emergency number.
Bus company VDL has come up with several innovative solutions to significantly reduce the spread of corona in buses with the help of air purification techniques.
Scientists at Berlin's Charité university hospital and TU Berlin have developed a new method that can accurately measure the amount of aerosol transferred from person to person.
At the Swiss Market Entry Bootcamp and Startup Days in Bern, 40 start-ups from 20 countries will present solutions for industries that are particularly affected by COVID-19.
Universities of Uppsala and Mainz are working separately on a drug against the covid-19 virus. The Swedish medicine is aimed at slowing down the virus, the German medicine is focused on prevention.